The Filing Desk

Cellebrite DI vs Strategy

Cellebrite DI CLBT · Strategy MSTR · Application Software

Strategy reported revenue of $477 million in fiscal 2025, about the same as Cellebrite DI's $476 million in fiscal 2025. Cellebrite DI's revenue grew 18.6% in its latest year, and Strategy's grew 3.0%. Cellebrite DI had an operating margin of 14.0%, against -1140.8% at Strategy. Free cash flow was $160 million at Cellebrite DI and −$75 million at Strategy.

Side by side

Cellebrite DIStrategy
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$476M$477M
Revenue growth18.6%3.0%
Revenue growth a year, last 5 years19.5%−0.1%
Gross margin84.2%68.7%
Operating margin14.0%−1,140.8%
Net margin16.5%−806.4%
Free cash flow$160M−$75M
Free cash flow margin33.7%−15.8%
Return on capital—−11.4%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count19.3%44.2%
Last close$11.32$86.13
P/E at the last close——
Insider trades, last 12 monthssold $5.5 millionbought $2.2 million, sold $30.5 million
Piotroski F-score—4 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Cellebrite DIStrategy
Operating margin
Percent of revenue
Cellebrite DIStrategy
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Cellebrite DIStrategy

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cellebrite DI and Strategy pages.